Literature DB >> 23341515

Adaptive randomization versus interim monitoring.

Boris Freidlin, Edward L Korn.   

Abstract

Mesh：

Year:  2013        PMID： 23341515     DOI： 10.1200/JCO.2012.45.0254

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.

Authors:  Brian M Alexander; Evanthia Galanis; W K Alfred Yung; Karla V Ballman; James M Boyett; Timothy F Cloughesy; John F Degroot; Jason T Huse; Bhupinder Mann; Warren Mason; Ingo K Mellinghoff; Tom Mikkelsen; Paul S Mischel; Brian P O'Neill; Michael D Prados; Jann N Sarkaria; Abdul Tawab-Amiri; Lorenzo Trippa; Xiaobu Ye; Keith L Ligon; Donald A Berry; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2014-08-26       Impact factor: 12.300

2.  The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children.

Authors:  John M VanBuren; T Charles Casper; Daniel K Nishijima; Nathan Kuppermann; Roger J Lewis; J Michael Dean; Anna McGlothlin
Journal:  Trials       Date:  2021-11-04       Impact factor: 2.279

3.  A Bayesian adaptive design for biomarker trials with linked treatments.

Authors:  James M S Wason; Jean E Abraham; Richard D Baird; Ioannis Gournaris; Anne-Laure Vallier; James D Brenton; Helena M Earl; Adrian P Mander
Journal:  Br J Cancer       Date:  2015-08-11       Impact factor: 7.640

4.  Unbiased estimation for response adaptive clinical trials.

Authors:  Jack Bowden; Lorenzo Trippa
Journal:  Stat Methods Med Res       Date:  2015-08-11       Impact factor: 3.021

5.  Master protocol trials in oncology: Review and new trial designs.

Authors:  Akihiro Hirakawa; Junichi Asano; Hiroyuki Sato; Satoshi Teramukai
Journal:  Contemp Clin Trials Commun       Date:  2018-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.